NIGMS, NIH Grant Qrono $256k Grant for Improvement of AMD Treatment

The National Institute of General Medicine Sciences, National Institute of Health have granted Qrono, a Pittsburgh-based pharmaceutical company, a $256,000 Small Business Technology Transfer Phase I grant for the improvement of wet age-related macular degeneration treatments.

Advertisement

The grant will also help fund the company’s work on long-acting injectable drug formulations.

The grant-funded research will be done in collaboration with The Little Lab of the Swanson School of Engineering at the University of Pittsburgh.

More Articles on Ophthalmology:
$600k Grant to Fund Telemedicine at Flaum Eye Institute
12 Statistics on Ophthalmologist Compensation by Setting
BIOLASE Earns US Patent for Laser Technologies

Advertisement

Next Up in Ophthalmology

  • Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

  • Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

  • The American Board of Ophthalmology has appointed Steven Gedde, MD, as its next CEO.  Dr. Gedde is an ophthalmologist and…

Advertisement

Comments are closed.